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ABSTRACT: Herbs are often co-administered with orthodox drugs, raising the potential for herb-drug 
interactions. This study investigated the pharmacological interaction between ethanol extract of Moringa oleifera 
(MOE) leaves and metformin co-administered to diabetic Wistar rats. Diabetes was induced in rats by administration 
of 150 mg alloxan/kg body weight intraperitoneally. A dose-response study for MOE at doses of 100-2000 mg/kg 
body wt. was carried out. A plot of percentage glycaemic reduction at 4h post-treatment versus log dose was used to 
estimate the median effective dose (ED50). Nine (9) groups of rats were used for the interaction study. Groups I and II 
served as normoglycaemic and diabetic controls respectively and received 1ml Normal saline. Diabetic Groups III-V 
received 375, 750 and 1500 mg/kg MOE respectively. Groups VI-VIII also diabetic received the same doses of MOE 
respectively but co-administered with a fixed dose of metformin (150 mg/kg). Group IX received metformin (150 
mg/kg) alone. Fasting blood sugar (FBS) was monitored weekly and blood samples collected on day 28 for protein 
and lipid profile assay. The MOE/metformin co-administered groups showed greater antihyperglycaemic activity 
(p<0.001) than the MOE and metformin alone groups. Significant increases in serum levels of cholesterol, TG and 
LDLC with the decrease in HDLC levels in the alloxan induced diabetic rats were reversed in MOE (p<0.01) and 
MOE/metformin (p<0.001) administered groups. These findings indicate that MOE/Metformin co-administration 
produced additive anti-hyperglycaemic and hypolipidaemic effects compared to either MOE or Metformin alone and 
may be useful in the therapeutic management of diabetes mellitus that is associated with dyslipidaemia. 
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INTRODUCTION 
Global use of herbal medicinal products and supplements 
has increased tremendously over the past three decades 
(Ekor, 2013). More than 80% of people in Africa and Asia use 
herbal medicines and an increasing number in the Western 
world (WHO, 1999). As the global use of herbal medicinal 
products continues to grow and many new drug products are 
introduced into the market, there may be an increase in the 
use of herbs alongside conventional drugs for better 
therapeutic outcomes (Vidushi, 2013).  
Diabetes mellitus is a chronic metabolic disease resulting 
from defects in insulin secretion, insulin action or both 
(Wadkar et al., 2008). Diabetes is characterized by 
hyperglycaemia which can be managed through diet, 
exercise, oral anti-diabetic agents, insulin replacement 
therapy and the use of herbs (Adikwu et al., 2010). 
Improperly managed hyperglycaemia predisposes patients to 
a number of infections and risk of developing microvascular 
and macrovascular complications (Claudia et al., 2006). To 
avert this, some patients co-use orthodox anti-diabetic agents 
alongside herbs that are used traditionally to decrease blood 
sugar (Mohammed & Mohammed, 2009).  
Moringa oleifera also known as horseradish tree is one of 
such herbs with antidiabetic activity (Tende et al., 2011). It is 
a fast growing drought-resistant tree belonging to the 
Moringaceae family. Various parts (leaves, flower and seed) 
of Moringa oleifera have been reported to possess 
antidiabetic activity (Jaiswal et al., 2009; Nku-Ekpang et al., 
2015). Due to its acclaimed therapeutic properties, availability 
and acceptability, it is often used with first-line orthodox 
antidiabetic agents such as metformin in the management of 
hyperglycaemia (Fasinu et al., 2011). 
The interaction between herbal preparations and orthodox 
medicinal drugs could either be pharmacodynamic or 
pharmacokinetic in nature. A pharmacodynamic interaction 
occurs when both the orthodox drug and the herb have 
affinity for the same receptors or physiological process while 
pharmacokinetic interaction results when the absorption, 
distribution, biotransformation or elimination of an orthodox 
drug is modified by a herbal product or vice versa resulting in 
an altered pharmacological response (Lal et al., 2011). Both 
pharmacodynamic and pharmacokinetic interactions can lead 
to additive, synergistic or antagonistic pharmacological 
activity. This study was undertaken to investigate the effect of 
co-administered ethanol extract of Moringa oleifera leaves 
and metformin on serum glucose levels, protein and lipid 
profiles in alloxan induced diabetic rats. 
 
MATERIALS AND METHODS 
Plant Materials and Preparation of Extracts 
Fresh leaves of M. oleifera were collected in Samaru, Sabon 
Gari Local Government Area of Kaduna State, Nigeria in 
April, 2013. The botanical identity was confirmed by Mallam 
U. Mohammed an ethno-botanist at the herbarium unit of the 
Department of Biological Sciences, Ahmadu Bello University, 
Zaria, Nigeria where a voucher specimen (Voucher No. 571) 
was deposited for future reference. 
The leaves were cleansed with distilled water to remove 
debris and dust particles. They were air dried to a constant 
weight and pulverized with a manual blender. A portion (800 
g) of the powdered leaves was cold macerated with ethanol 
for 24 hours and filtered with Whatman filter paper (Size No1) 
to obtain M. oleifera ethanolic extract (MOE). The extract was 
evaporated to dryness over a water bath maintained at 40oC 
and stored in a refrigerator until required for use. 
Materials  
Metformin 500mg tablets (Glucophage®, Merke Sante s.a.s 
France) was purchased locally, Alloxan monohydrate 
(powder) and absolute ethanol were purchased from the 
country representative of Sigma Chemical, St. Loius USA 
while a digital glucometer and corresponding test strips (Fine 
Test®, Infopia Co., Ltd. USA) was purchased from a 
pharmacy store. All other chemicals used were of analar 
grade and obtained commercially. 
Experimental Animals 
Healthy Wistar rats of either sex weighing 100-150g, 
purchased from the Animal Facility Centre (AFC), 
Department of Pharmacology and Toxicology, of the National 
Institute for Pharmaceutical Research and Development 
(NIPRD), Idu, Abuja, Nigeria were used for the study.  They 
were kept in stainless steel cages under 12/ 12 hour light/ 
dark cycles at standard laboratory conditions of temperature 
22±1oC, relative humidity 14±1% and 12h light /dark cycle. 
They were maintained on clean water and standard rodent 
chow. All experiments were performed according to the 
“Principles of Laboratory Animal Care” (NIH and NIPRD 
Standard Operating Procedures (SOPs) for pharmacological 
studies involving whole animals. 
Acute toxicity study 
The oral median lethal dose (LD50) of the extract was 
determined in rats according to the method described by 
Lorke (1983) but with slight modifications. The study was 
carried out in two phases. In the first phase, nine rats were 
randomized into three groups of three rats which were given 
10, 100, and 1000mg extract/kg body weight. The rats were 
kept under the same conditions and observed for signs of 
toxicity which included but were not limited to paw-licking, 
stretching, respiratory distress and mortality for the first 4h 
and thereafter daily for two weeks. Based on the results of 
the initial phase, the following doses- 1600, 1900 and 
5000mg extract/kg body weight were administered to another 
set of three groups of three rats in the second phase. These 
rats were also monitored closely for the first 4 h after 
treatment and subsequently daily for 14 days for signs of 
toxicity and/or mortality. The results obtained in the second 
phase were used to calculate the LD50. 
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Induction of hyperglycaemia 
The method described by Stein (1987) was adopted.  
Diabetes was induced in rats fasted overnight by 
administering freshly prepared 150 mg alloxan/kg 
intraperitoneally. The animals were thereafter allowed food 
and water ad libitum. After 72 hours, the blood glucose levels 
in the rats were determined following an overnight fast, using 
a Fine Test® digital glucometer and the corresponding test 
strip. Rats having fasting blood glucose (FBS) levels ≥ 200 
mg/dl were considered hyperglycaemic. 
Dose-response study 
Forty-eight (48) rats having FBS level ≥ 200 mg/dl were 
randomized into 8 groups of 6 rats each. The rats in group 1 
served as diabetic control and received 10 ml/kg body weight 
of distilled water orally, groups 2, 3, 4, 5, 6 and 7 rats were 
administered 100, 200, 400, 800, 1000 and 2000 mg 
extract/kg body weight respectively while group 8 received 
metformin at a dose of 150 mg/kg. Post-treatment blood 
glucose concentration (BGC) was measured hourly with a 
glucometer using the blood samples collected from the tail tip 
of rats. The blood glucose level monitoring was done for 4h 
and a plot of percentage glycaemic reduction at 4 h versus 
log dose was used to estimate the ED50 (dose required to 
produce 50% glycaemic reduction in diabetic rats) of the 
extract.  
Pharmacological interaction studies 
Fifty-four (54) rats having FBS level ≥ 200 mg/dl were 
randomized into 9 groups of 6 rats each and treated as 
follows. Groups I and II served as normoglycaemic and 
diabetic controls respectively. Groups III, IV and V were given 
375, 750 and 1500 mg/kg of MOE alone orally while Groups 
VI, VII and VIII rats received 150 mg/kg of Metformin with 
375, 750 and 1500 mg/kg of MOE respectively while Group 
IX rats received150mg of Metformin/kg body weight alone for 
28 days. 
Determination of Biochemical Parameters  
Fasting blood sugar determination: Blood samples were 
obtained from the tail vein of the rats and glucose level was 
estimated on 0, 7, 14, 21 and 28th day of the study by 
FineTest® glucometer 
Lipid profile assay: On the last day of the experiment, 
overnight fasted rats were euthanized by chloroform 
inhalation. Blood samples were collected via cardiac puncture 
into plain sera tubes and allowed to clot. Serum was 
separated by centrifugation [using DenleyBS400 centrifuge 
(England) with swing-out rotor system, ×1500g at 20 oC, for 
10 min and then assayed for levels of total protein, albumin, 
total cholesterol (Tchol.), triglyceride (TG), high density 
lipoprotein cholesterol (HDL-C) and low density lipoprotein 
cholesterol (LDL-C). 
Assay for serum total cholesterol: The serum level of total 
cholesterol was quantified after enzymatic hydrolysis and 
oxidation of the sample as described by the method of Stein 
(1987).  
Assay for serum triglyceride: The serum triglyceride level was 
determined after enzymatic hydrolysis of the sample with 
lipases as described by the method of Tietz (1990). 
Assay for serum high density lipoprotein cholesterol:The 
serum level of HDL-C was estimated by the method of   
Wacnic and Alber (1978).  
Determination of serum low-density lipoprotein cholesterol: 
The serum level of (LDL-C) was calculated according to the 
method of Friedewald et al. (1972) using the equation below: 
LDL-C = TG/5-HDL-C. The value was expressed in mg/dl. 
Serum protein and serum albumin: Serum protein and serum 
albumin were estimated by Biuret method and Bromocresol 
Green (BCG) binding methods respectively using a 
commercial assay kit from Randox Laboratories Ltd. 
Statistical analysis 
All data were expressed as mean ± Standard Error of Mean 
(SEM) and statistical differences between means were 
determined by one-way ANOVA followed by Dunnett’s post – 
hoc test for multiple comparison tests using GraphPad 





Yield of Extract 
The yield of the ethanol extract was calculated to be 12.07% 
w/w. 
Acute toxicity study 
In both phases of the experiment, there were no signs of 
toxicity or mortality during the acute monitoring and 14 day 
monitoring periods. The oral LD50 value was estimated to be 
greater than 5000 mg/kg body weight in rats. 
Dose-response study 
Moringa oleifera ethanol leaf extract produced significant 
(p<0.05), dose- and time-dependent reduction in FBS when 
compared to the control (Table 1). 
 
IDAKWOJI  et al.              Leaf extract of Moringa oleifera and Metformin improves biochemical parameters in diabetic Wistar Rats        Biokemistri 27(3): 129–138 
 132	
Table 1: Effect of Ethanol Extract of Moringa oleifera Leaves 
(MOE) and Metformin on Fasting Blood Sugar of Alloxan-
induced Hyperglycaemic Rats at different timed Intervals. 
	
N=6, *p < 0.05, **p <0.01, ***p< 0.001 compared with the control. 
Values in parenthesis represent percentage glycaemic reduction at 
the various hours. 
Estimation of Effective Median Dose (ED50) of Ethanol 
Extract of M. oleifera Leaves.  
From the dose-response data, a plot of percentage glycaemic 
reduction at 4h against log dose, the ED50 of MOE was 
estimated to be approximately 750 mg/kg. (Figure 1) 
Effect of Ethanolic Extract of M. oleifera Leaves (MOE), 
Metformin and MOE/ Metformin Co-administration on 
FBS of Rats.  
When compared to diabetic control, MOE (375 mg/kg) 
produced a significant (p< 0.05) reduction in FBS only on day 
28. On days 21 and 28, MOE (750 mg/kg) produced highly 
significant (p<0.01) reduction in FBS while MOE (1500mg/kg) 
produced a  significant  dose-dependent  reduction in FBS on 
day 7 (p<0.05), days 14, 21 and 28 (p<0.01) respectively.The 
co-administration of MOE (375 mg/kg)/Metformin and MOE 
(750 mg/kg)/Metformin significantly reduced FBS on day 7 
(p<0.05), days 14 and 21 (p< 0.01) and day 28 (p< 0.001) 
respectively when compared to control MOE (1500 mg/kg). 
Metformin also produced significant (p< 0.001) reductions on 
days 7, 14, 21 and 28. Metformin alone showed significant 
(p<0.05), (p< 0.01) reduction in FBS on day 14 and days 21 
and 28 respectively when compared to the diabetic control 
(Table 2). 
	
Figure 1:  Log dose-Response Curve of M. Oleifera leave extract 
4 hours post-treatment.  
 
Effect of Ethanol Extract of M. oleifera Leaves (MOE), 
Metformin (Met) and MOE/Metformin co-administration 
on some Serum Total Protein and Albumin 
Concentrations of Rats.  
Rats in groups that were treated alone with MOE (1500 
mg/kg), 375 mg/kg MOE/Metformin, 750 mg/kg/Metformin, 
1500 mg/kg MOE/Metformin and Metformin produced highly 
significant (p<0.001) increase in total protein and albumin 
compared to diabetic control (Figure 2). 
Effect of Ethanol Extract of M. oleifera Leaves (MOE), 
Metformin (Met) and MOE/Metformin Co-administration 
on Serum Total Cholesterol Level of Diabetic Rats.  MOE 
at the doses of 750 and 1500mg/kg significantly (p<0.01), 
(p<0.001) respectively decreased the serum level of total 
cholesterol when compared to the diabetic control. At all the 
doses of the extract co-administered with metformin, a highly 
significant (p<0.001) reduction in serum total cholesterol 
levels was observed compared to diabetic control. Similar 
observation was made with metformin alone group rats 
(Figure 3). 
Effect of Ethanol Extract of M. oleifera Leaves (MOE), 
Metformin (Met) and MOE/Metformin Co-administration 
on Serum Triglyceride Level of Diabetic Rats. 
There were statistically significant (p<0.05), (p<0.01) 
decreases in the level of serum triglyceride in the diabetic 
groups treated with MOE doses of 750 and 1500 mg/kg 
respectively. Metformin alone at 150 mg/kg showed highly 
significant (p<0.01) decrease in serum triglyceride level when 
compared to diabetic control group. Meanwhile the 375, 750 
and 1500 mg/kg of MOE co-administered with metformin 
produced very highly significant reduction (p>0.001), when 
compared to the diabetic control (Figure 4). 









Effect of Ethanol Extract of M. oleifera Leaves (MOE), 
Metformin (Met) and MOE/Metformin co-administration 
on serum HDL-C Level of Diabetic Rats 
Serum HDL-C level was significantly elevated (p<0.001) only 
in all the MOE/metformin co-administered groups when 
compared to the diabetic control (Figure 5). 
Effect of Ethanol Extract of M. oleifera leaves (MOE), 
Metformin (Met) and MOE/Metformin Co-administration 
on Serum LDL-C level of Diabetic Rats  
There were dose-dependent significant (p<0.05, p<0.01 and 
p<0.001 respectively) reductions in the serum level of LDL-C 
in the groups administered with MOE at the doses of 375, 
750 and 1500 mg/kg when compared to the diabetic control. 
The extract at all doses co-administered with metformin 
showed highly significant decrease (p<0.001) in serum level 
of LDL-C while metformin alone group rats showed a 
significant (p<0.05) decrease in serum LDL-C when 










The acute toxicity study of the extract revealed that the oral 
LD50 value is greater than 5000 mg/kg. This is in agreement 
with the study of Bakre et al. (2013) in which it was reported 
that the oral LD50 of the ethanol extract of M. oleifera leaves 
was greater than 6400 mg/kg in mice. The extract is therefore 
considered practically non-toxic. This implies that the extract 
can be consumed at higher doses without fear of toxicity. 
This study also estimated the median effective dose (ED50) of 
the extract to be 750 mg extract/kg. This further confirms that 
the extract possesses a wide safety margin since the LD50 
value is far greater than the ED50. 
Alloxan, used to induce diabetes acts by selectively 
destroying the insulin- producing beta cells of the Islet of 
Langerhans producing hypoinsulinaemia (Szkudelski, 2001). 
This resultant insulin deficiency, leads to various metabolic 
alterations in the animals such as, increase in blood glucose, 
dyslipidemia and alterations in serum protein profile (Vivek et 
al., 2010).  
Table 2:  Effect of Ethanolic Extract of M. oleifera Leaves (MOE), Metformin (Met) and MOE 
/Metformin Co-administration on FBS of Hyperglycaemic Rats. 
 
N=6, *p <0.05, **p <0.01, ***p <0.001 and ap<0.05, bp<0.01, cp<0.001 compared with the diabetic 
control (DC) and normoglycaemic control (NC) respectively. 






Figure 2: Effect of Ethanol Extract of M. oleifera Leaves (MOE), 
and MOE/Metformin co-administration on serum Total protein 
and Albumin levels of Alloxan-induced diabetic Wistar rats. n=6 
,   *p <0.05, **p <0.01, ***p <0.001 and ap<0.05, bp<0.01, cp<0.001 
compared with the diabetic control (DC) and normoglycaemic 





Figure 3: Effect of Ethanol Extract of M. oleifera (MOE) and 
MOE/Metformin Co-administration on Serum Total Cholesterol 
Level of Alloxan-induced Diabetic Wistar Rats. n = 6,*p <0.05, 
**p<0.01, ***p <0.001 and ap<0.05, bp<0.01, cp<0.001 statistically 
significant compared with the diabetic control (DC) and 







Figure 4: Effect of ethanol extract of M. oleifera leaves (MOE) 
and MOE/Metformin co-administration on serum triglyceride 
level of Alloxan-induced diabetic Wistar rats. n=6. *p <0.05, **p 
<0.01, ***p <0.001 and ap<0.05, bp<0.01, cp<0.001 compared with 





Figure 5: Effect of Ethanol Extract of M. oleifera leaves (MOE) 
and MOE/Metformin co-administration on serum HDL-C level of 
Alloxan-induced diabetic Wistar rats. n=6. *p <0.05, **p <0.01, 
***p <0.001 and ap <0.05, bp<0.01, cp<0.001 compared with the 
diabetic control (DC) and normoglycaemic control (NC) 
respectively. 
 





Figure 6: Effect of Ethanol Extract of M. oleifera leaves (MOE) 
and MOE/Metformin Co-administration on Serum LDL-C Level of 
Alloxan-induced Diabetic Wistar Rats. n=6, *p <0.05, **p <0.01, 
***p <0.001 and ap<0.05, bp<0.01, cp<0. compared with the 
diabetic control (DC) and normoglycaemic control (NC) 
respectively. 
 
The significant, dose and time- dependent reduction in blood 
glucose level produced in alloxan-induced hyperglycaemic 
rats by ethanol extract of Moringa oleifera leaves is in 
agreement with those of other researchers, who 
systematically demonstrated that extracts of various parts of 
the plant (leaves, flowers and seed) possess antidiabetic 
properties (Tende et al., 2011; Jaiswal et al., 2009). In a 
controlled study with untreated type 2 diabetes mellitus 
patients, (William et al., 1993) reported the anti-
hyperglycaemic activity of the Moringa oleifera leaves. 
Kumari (2010) also reported significant hypoglycaemic effect 
of M. oleifera leaf dietary consumption in Type 2 diabetes 
mellitus (T2DM) patients, and reported that it reduced 
glucose level significantly after a 40-day period.  
The therapeutic actions of Moringa oleifera medication have 
been attributed to the relatively high antioxidant activity of its 
leaves, flowers, and seeds (Atawodi et al., 2010). Quercetin 
and kaemferol found in Moringa oleifera leaves were shown 
to be antioxidant in nature (Fuglie, 1999). Hypoglycaemic 
activity of kaemferol derivatives from many medicinal plants 
has been reported by Desoky & Yousef (1997). These 
antioxidants might have played a role in scavenging the free 
radicals generated by alloxan leading to the regeneration of 
the beta-cells destroyed by alloxan, hence an increase in 
release of insulin and reduction in glycaemia. The extract 
might have also produced anti-hyperglycaemic activity 
through direct release of insulin by inhibiting the ATP-
sensitive potassium channels in the membrane of the 
residual beta-cells just like sulfonylureas and meglitinides. It 
is also possible that the extract might have potentiated the 
action of insulin to stimulate glucose uptake and utilization by 
tissues, especially by the liver, skeletal muscle, and adipose 
tissue (Gerich, 2000). 
Dyslipidemia which includes not only quantitative but also 
qualitative abnormalities of lipoprotein plays a significant role 
in the proatherogenesis of vascular complications in diabetes 
mellitus (Rotimi et al., 2011). Lowering of serum lipid levels 
through herbal or drug therapy seems to be associated with a 
decrease in the risk of vascular disease in diabetes (Claudia 
et al., 2006). In this study, following alloxan treatment, there 
was an elevation in serum concentration of total cholesterol, 
triglyceride, low-density lipoprotein cholesterol (LDL-C) and a 
decrease in HDL-C in rats. Daisy et al. (2009) and Eze et al. 
(2012) also reported increased plasma cholesterol, 
triglycerides, LDLC and decreased HDL-C in streptozocin-
induced hyperglycemic rats. According to Mathe (1995), the 
observed increase in serum cholesterol level results from 
increased intestinal absorption and synthesis of cholesterol. 
Nimenibo-Uadia (2003) suggested that diabetes-induced 
hyperlipidemia is attributable to excess mobilization of fat 
from the adipose due to under utilization of glucose. Insulin 
deficiency and elevations of the counter-regulatory hormones 
lead to activation of enzymes (hormone-sensitive lipase) that 
stimulate lipolysis and enhanced release of free fatty acids 
from adipose tissues which are mobilized for energy purpose 
(Rotimi et al., 2011). The excess fatty acids are afterwards 
accumulated in the liver and converted to triglyceride 
(Suryawanshi et al. 2006). The unregulated action of lipolytic 
hormones on the fat depots is therefore responsible for the 
hyperlipidemia that characterizes diabetes (Claudia et al., 
2006).  
The significant decrease in serum lipid profile levels observed 
with Moringa oleifera and its co-administration may 
presumably be mediated by a control of lipid metabolism by 
some of the reported phytochemicals present in the plant. 
Moringa oleifera leaves are a rich source of glycosides, 
phenols, saponins and sterols. Beta-sitosterol, one of such 
sterols in the leaves lowers cholesterol level by inhibiting its 
re-absorption from endogenous sources with a simultaneous 
increase in its excretion into faeces in the form of neutral 
steroids (Kumarappen et al., 2007). Saponins also lower 
cholesterol by binding with cholesterol in the intestinal lumen, 
preventing its absorption and/or by binding with bile acids, 
causing a reduction in the entero-hepatic circulation of bile 
acids and increase in its fecal excretion (Gerich, 2000). 
Increased bile acid excretion is offset by enhanced bile acid 
synthesis from cholesterol in the liver and consequent 
lowering of the plasma cholesterol 29. Polyphenolic 
compounds possess hypolipidemic properties (Kumarappen 
et al., 2007).  Thus, the observed anti-hypercholesterolemic 
effect of Moringa oleifera could be linked to the high 
polyphenolic content of its leaves.  
Additive cholesterol-lowering activity was observed with 
Moringa oleifera/ Metformin co-administeration as it produced 
highly significant reduction compared to either of the extract 
IDAKWOJI  et al.              Leaf extract of Moringa oleifera and Metformin improves biochemical parameters in diabetic Wistar Rats        Biokemistri 27(3): 129–138 
 136	
or metformin alone. Metformin produces its anti-
hypercholesterolemic effect mainly by correcting abnormal 
glucose metabolism (Defronzo & Goodman,1995).  
The extract/metformin co-administration also produced a 
synergistic decrease in serum triacylglycerol level, which was 
more than that of the extract at all, the doses administered. 
Metformin is known to produce reduction in serum triglyceride 
levels as a result of decreased hepatic synthesis of very low-
density lipoprotein (Chehade, 2000) and the extract might 
have acted through an alteration in the level of interleukin-6 
(IL-6) which mediates energy mobilization in the muscles and 
fat tissues (Oyewo & Akanji, 2010). In addition, reduction in 
the serum cholesterol level in this study does not seem to be 
accompanied by lipolysis, as seen in the reduction in the 
serum triacylglycerol levels. From this study, it could be 
inferred that the extract will only produce synergistic serum 
triacylglyceride lowering activity with metformin at a high 
dose.  
The dose-dependent and additive increase in the serum 
HDL-C level by the extract and extract/metformin co-
administration respectively could possibly be due to an 
increase in the biosynthesis of HDL-C in the liver by the 
presence of flavonoids in the extract (Renaud et al., 1999). 
With increase in HDL-C serum level, there was possibly an 
enhanced cholesterol excretion as more of it might have been 
transported from the peripheral tissues to the liver for 
excretion by HDL-C. The observed dose dependent decrease 
in the serum LDL-C levels may explain the serum cholesterol-
lowering capability of M. oleifera extract. This effect could 
possibly be due to enhanced reverse cholesterol transport 
and bile acid excretion through inhibition of apo B production, 
needed for LDL-C production, transport and binding (Libby, 
2011). The extract co-administered with metformin reduced 
serum level of LDL-C more than either metformin or the 
extract administered alone, this implies a synergistic 
interaction. The observed synergistic increase and decrease 
in the serum HDL-C and LDL-C respectively, is beneficial in 
diabetes as it reduces the risk of developing atherosclerosis 
(Libby, 2011). 
Serum albumin and total protein concentration was 
significantly decreased in alloxan-treated rats when 
compared with the non-diabetic rats. Proteins are important 
building blocks of all cells and tissues. They form the 
structural part of most organs and make up enzymes and 
hormones that regulate body functions   (Pagana & Pagana, 
2006). The low protein level observed in this study may be as 
a result of overproduction of globulins, such as seen in 
multiple myeloma or autoimmune diseases or 
underproduction of albumin (Burtis et al, 2006). Albumin 
plays an important physiological role by maintaining osmotic 
pressure, transport of both endogenous and exogenous 
substance and serving as protein reserves (Saidu et al., 
2007). The liver’s ability to synthesize albumin is reduced if 
the synthetic function of the liver is tampered with (Whitby et 
al., 1989) and is an indication of hepatitis and liver cirrhosis. 
However, the results of this study showed that, the treatment 
of diabetic rats with M. oleifera and M. oleifera 
extract/metformin co-administeration brought about marked 
increase in serum total protein contents. The 
extract/metformin co-administeration showed synergistic 
effect as the total protein and albumin in these groups 
increased more than the groups administered the extract or 
metformin alone. This increment could be as a result of the 
reversal of hepatic damage. Hence, increase in hepatic 
uptake of amino acids, stimulation of amino acid 
incorporation into protein and decreased proteolysis by 
activating the enzyme that catalyzes amino acids 
transamination (Nahla et al., 2006). 
In this study, the anti-diabetic activity of the extract/metformin 
co-administeration was significantly higher than the anti-
diabetic activity of the extract at all the doses administered 
and metformin. This suggests that the extract and metformin 
showed additive anti-hyperglycaemic activities possibly due 
to the additive beta-cell regeneration shown by the co-
administeration which must have led to more insulin 
secretion. The wide safety margin of the extract and its 
positive effect on lipid and protein profile in the combination 
makes it useful in preventing arteriosclerosis and 
cardiovascular diseases associated with diabetes mellitus. 
Conclusion 
The anti-diabetic activity observed with co-administration of 
metformin and Moringa oleifera was significantly more than 
either of the drug or extract administered alone. It was 
concluded that Moringa oleifera shows synergistic effect with 
metformin on blood glucose levels, protein and lipid profiles. 
This could be important in reducing the dose of metformin to 
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